Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05174923 · ClinicalTrials.gov registry record
Variability of Physical Assessments in an Older Population That is Overweight or Obese
A clinical trial of Obesity and Aging, sponsored by Versanis Bio.
- Completed
- Registry status
- 58
- Enrollment target
- 2
- Study locations
NCT05174923: Completed study of Obesity and Aging, sponsored by Versanis Bio.
NCT05174923 is a study of Obesity and Aging that has completed, run by Versanis Bio. The registered enrollment target is 58 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05174923, a study of Obesity and Aging, has completed, sponsored by Versanis Bio.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
- 2
- Study locations
Study Summary
Variability of physical assessments in an older population that is overweight or obese.
Interventions
- BEHAVIORAL Short Performance Physical Battery (SPPB Test)
- BEHAVIORAL 30 Second Chair Stand Test (30CST)
- BEHAVIORAL Hand grip dynamometry
Study Locations (2)
Florida
- CNS Healthcare - Jacksonville
- CNS Healthcare - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2021-11-05 |
What the finished NCT05174923 record still lists
NCT05174923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Short Performance Physical Battery (SPPB Test) is the first listed.
NCT05174923 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05174923 about?
NCT05174923 is a clinical study titled "Variability of Physical Assessments in an Older Population That is Overweight or Obese". Variability of physical assessments in an older population that is overweight or obese.
What is the current status of trial NCT05174923?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2021-09-20. Estimated completion is 2021-11-05.
What conditions does trial NCT05174923 study?
This clinical trial studies the following conditions: Obesity, Aging.
What interventions are being tested in trial NCT05174923?
The interventions under investigation include: Short Performance Physical Battery (SPPB Test) (BEHAVIORAL), 30 Second Chair Stand Test (30CST) (BEHAVIORAL), Hand grip dynamometry (BEHAVIORAL).
Who is sponsoring clinical trial NCT05174923?
This trial is sponsored by Versanis Bio, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05174923 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05174923's enrollment target sits among peer trials
58 684th of 1053 higher than 367 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI